The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

(2020) Jiabao Xu et al.   Viruses-Basel

Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients

(2020) Suxin Wan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

CT imaging of coronavirus disease 2019 (COVID-19): from the qualitative to quantitative

(2020) Xiaolong Qi et al.   Annals of Translational Medicine

The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China

(2020) You Zou et al.   JOURNAL OF INFECTIOUS DISEASES

Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis

(2019) Gaohong Sheng et al.   CHEST

Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores

(2017) Joseph Jacob et al.   EUROPEAN RADIOLOGY

Global perspectives of emerging occupational and environmental lung diseases

(2015) Subhabrata Moitra et al.   CURRENT OPINION IN PULMONARY MEDICINE

Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy

(2015) P. Spagnolo et al.   PHARMACOLOGY & THERAPEUTICS

The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status

(2010) Jenny C. NGAI et al.   RESPIROLOGY